GSE58827: Dynamics of the Mouse Liver
Gene Symbol | Gene ID | Gene Info |
---|---|---|
Hoxb2
|
ENSMUSG00000075588.7 | homeobox B2 |
Dlx2
|
ENSMUSG00000023391.9 | distal-less homeobox 2 |
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
Hoxb2 | mm39_v1_chr11_+_96242422_96242461 | -0.62 | 6.2e-05 | Click! |
Dlx2 | mm39_v1_chr2_-_71377088_71377103 | -0.34 | 4.4e-02 | Click! |
Promoter | Log-likelihood | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr16_+_22737128 | 6.24 |
ENSMUST00000170805.9
|
Fetub
|
fetuin beta |
chr16_+_22737227 | 6.15 |
ENSMUST00000231880.2
|
Fetub
|
fetuin beta |
chr16_+_22737050 | 5.99 |
ENSMUST00000231768.2
|
Fetub
|
fetuin beta |
chr19_-_7943365 | 5.96 |
ENSMUST00000182102.8
ENSMUST00000075619.5 |
Slc22a27
|
solute carrier family 22, member 27 |
chr3_+_59989282 | 4.76 |
ENSMUST00000029326.6
|
Sucnr1
|
succinate receptor 1 |
chrM_+_10167 | 3.70 |
ENSMUST00000082414.1
|
mt-Nd4
|
mitochondrially encoded NADH dehydrogenase 4 |
chr1_-_140111138 | 3.03 |
ENSMUST00000111976.9
ENSMUST00000066859.13 |
Cfh
|
complement component factor h |
chrM_+_9870 | 2.96 |
ENSMUST00000084013.1
|
mt-Nd4l
|
mitochondrially encoded NADH dehydrogenase 4L |
chr1_-_140111018 | 2.89 |
ENSMUST00000192880.6
ENSMUST00000111977.8 |
Cfh
|
complement component factor h |
chr9_-_71070506 | 2.83 |
ENSMUST00000074465.9
|
Aqp9
|
aquaporin 9 |
chr5_-_87240405 | 2.80 |
ENSMUST00000132667.2
ENSMUST00000145617.8 ENSMUST00000094649.11 |
Ugt2b36
|
UDP glucuronosyltransferase 2 family, polypeptide B36 |
chr3_+_62327089 | 2.54 |
ENSMUST00000161057.2
|
Arhgef26
|
Rho guanine nucleotide exchange factor (GEF) 26 |
chr15_+_31224616 | 2.41 |
ENSMUST00000186547.7
|
Dap
|
death-associated protein |
chr10_+_127734384 | 2.31 |
ENSMUST00000047134.8
|
Sdr9c7
|
4short chain dehydrogenase/reductase family 9C, member 7 |
chr11_-_99213769 | 2.20 |
ENSMUST00000038004.3
|
Krt25
|
keratin 25 |
chr14_+_51333816 | 2.15 |
ENSMUST00000169895.3
|
Rnase4
|
ribonuclease, RNase A family 4 |
chr17_-_35100980 | 1.94 |
ENSMUST00000152417.8
ENSMUST00000146299.8 |
C2
Gm20547
|
complement component 2 (within H-2S) predicted gene 20547 |
chr14_+_33662976 | 1.92 |
ENSMUST00000100720.2
|
Gdf2
|
growth differentiation factor 2 |
chr14_+_55797468 | 1.86 |
ENSMUST00000147981.2
ENSMUST00000133256.8 |
Dcaf11
|
DDB1 and CUL4 associated factor 11 |
chr2_+_67935015 | 1.83 |
ENSMUST00000042456.4
|
B3galt1
|
UDP-Gal:betaGlcNAc beta 1,3-galactosyltransferase, polypeptide 1 |
chr15_-_60793115 | 1.81 |
ENSMUST00000096418.5
|
A1bg
|
alpha-1-B glycoprotein |
chr5_-_87716882 | 1.76 |
ENSMUST00000113314.3
|
Sult1d1
|
sulfotransferase family 1D, member 1 |
chr19_+_44980565 | 1.73 |
ENSMUST00000179305.2
|
Sema4g
|
sema domain, immunoglobulin domain (Ig), transmembrane domain (TM) and short cytoplasmic domain, (semaphorin) 4G |
chr15_+_31224555 | 1.70 |
ENSMUST00000186109.2
|
Dap
|
death-associated protein |
chr13_-_53627110 | 1.67 |
ENSMUST00000021922.10
|
Msx2
|
msh homeobox 2 |
chr1_+_74324089 | 1.63 |
ENSMUST00000113805.8
ENSMUST00000027370.13 ENSMUST00000087226.11 |
Pnkd
|
paroxysmal nonkinesiogenic dyskinesia |
chr1_+_88128323 | 1.62 |
ENSMUST00000049289.9
|
Ugt1a2
|
UDP glucuronosyltransferase 1 family, polypeptide A2 |
chr17_-_35101069 | 1.61 |
ENSMUST00000025230.15
|
C2
|
complement component 2 (within H-2S) |
chr17_-_84154196 | 1.49 |
ENSMUST00000234214.2
|
Haao
|
3-hydroxyanthranilate 3,4-dioxygenase |
chr6_+_37847721 | 1.49 |
ENSMUST00000031859.14
ENSMUST00000120428.8 |
Trim24
|
tripartite motif-containing 24 |
chr7_-_48497771 | 1.37 |
ENSMUST00000032658.14
|
Csrp3
|
cysteine and glycine-rich protein 3 |
chr3_-_75177378 | 1.35 |
ENSMUST00000039047.5
|
Serpini2
|
serine (or cysteine) peptidase inhibitor, clade I, member 2 |
chr10_+_53213763 | 1.34 |
ENSMUST00000219491.2
ENSMUST00000163319.9 ENSMUST00000220197.2 ENSMUST00000046221.8 ENSMUST00000218468.2 ENSMUST00000219921.2 |
Pln
|
phospholamban |
chr18_-_39000056 | 1.34 |
ENSMUST00000236630.2
ENSMUST00000237356.2 |
Fgf1
|
fibroblast growth factor 1 |
chr2_+_22959452 | 1.32 |
ENSMUST00000155602.4
|
Acbd5
|
acyl-Coenzyme A binding domain containing 5 |
chr5_+_90708962 | 1.31 |
ENSMUST00000094615.8
ENSMUST00000200765.2 |
Albfm1
|
albumin superfamily member 1 |
chrM_+_7006 | 1.29 |
ENSMUST00000082405.1
|
mt-Co2
|
mitochondrially encoded cytochrome c oxidase II |
chr4_-_104733580 | 1.28 |
ENSMUST00000064873.9
ENSMUST00000106808.10 ENSMUST00000048947.15 |
C8a
|
complement component 8, alpha polypeptide |
chr16_+_42727926 | 1.28 |
ENSMUST00000151244.8
ENSMUST00000114694.9 |
Zbtb20
|
zinc finger and BTB domain containing 20 |
chr17_-_84154173 | 1.28 |
ENSMUST00000000687.9
|
Haao
|
3-hydroxyanthranilate 3,4-dioxygenase |
chr7_+_51528788 | 1.28 |
ENSMUST00000107591.9
|
Gas2
|
growth arrest specific 2 |
chr12_+_111780604 | 1.28 |
ENSMUST00000021714.9
ENSMUST00000223211.2 ENSMUST00000222843.2 ENSMUST00000221375.2 |
Zfyve21
|
zinc finger, FYVE domain containing 21 |
chr10_-_44024843 | 1.27 |
ENSMUST00000200401.2
|
Crybg1
|
crystallin beta-gamma domain containing 1 |
chr6_-_138056914 | 1.27 |
ENSMUST00000171804.4
|
Slc15a5
|
solute carrier family 15, member 5 |
chr2_-_165997551 | 1.25 |
ENSMUST00000109249.9
ENSMUST00000146497.9 |
Sulf2
|
sulfatase 2 |
chr3_-_157630690 | 1.21 |
ENSMUST00000118539.2
|
Cth
|
cystathionase (cystathionine gamma-lyase) |
chr19_-_42117420 | 1.20 |
ENSMUST00000161873.2
ENSMUST00000018965.4 |
Avpi1
|
arginine vasopressin-induced 1 |
chr18_-_38999755 | 1.19 |
ENSMUST00000115582.8
ENSMUST00000236060.2 |
Fgf1
|
fibroblast growth factor 1 |
chr1_+_88093726 | 1.17 |
ENSMUST00000097659.5
|
Ugt1a5
|
UDP glucuronosyltransferase 1 family, polypeptide A5 |
chr11_-_43792013 | 1.16 |
ENSMUST00000067258.9
ENSMUST00000139906.2 |
Adra1b
|
adrenergic receptor, alpha 1b |
chrM_+_9459 | 1.15 |
ENSMUST00000082411.1
|
mt-Nd3
|
mitochondrially encoded NADH dehydrogenase 3 |
chr2_-_165997179 | 1.14 |
ENSMUST00000088086.4
|
Sulf2
|
sulfatase 2 |
chr13_+_23991010 | 1.13 |
ENSMUST00000006786.11
ENSMUST00000099697.3 |
Slc17a2
|
solute carrier family 17 (sodium phosphate), member 2 |
chr16_+_37400590 | 1.12 |
ENSMUST00000159787.8
|
Hgd
|
homogentisate 1, 2-dioxygenase |
chr3_-_49711765 | 1.12 |
ENSMUST00000035931.13
|
Pcdh18
|
protocadherin 18 |
chr16_+_37400500 | 1.09 |
ENSMUST00000160847.2
|
Hgd
|
homogentisate 1, 2-dioxygenase |
chr7_-_100306160 | 1.06 |
ENSMUST00000107046.8
ENSMUST00000107045.9 ENSMUST00000139708.9 |
Plekhb1
|
pleckstrin homology domain containing, family B (evectins) member 1 |
chr17_+_14087827 | 1.05 |
ENSMUST00000239324.2
|
Afdn
|
afadin, adherens junction formation factor |
chr2_+_70305267 | 1.03 |
ENSMUST00000100043.3
|
Sp5
|
trans-acting transcription factor 5 |
chr6_-_115569504 | 1.03 |
ENSMUST00000112957.2
|
Mkrn2os
|
makorin, ring finger protein 2, opposite strand |
chr7_+_126549692 | 1.02 |
ENSMUST00000106335.8
ENSMUST00000146017.3 |
Sez6l2
|
seizure related 6 homolog like 2 |
chrM_+_11735 | 1.02 |
ENSMUST00000082418.1
|
mt-Nd5
|
mitochondrially encoded NADH dehydrogenase 5 |
chr14_+_55797443 | 1.01 |
ENSMUST00000117236.8
|
Dcaf11
|
DDB1 and CUL4 associated factor 11 |
chr5_+_90666791 | 1.01 |
ENSMUST00000113179.9
ENSMUST00000128740.2 |
Afm
|
afamin |
chr7_+_51530060 | 1.00 |
ENSMUST00000145049.2
|
Gas2
|
growth arrest specific 2 |
chr3_-_49711706 | 0.99 |
ENSMUST00000191794.2
|
Pcdh18
|
protocadherin 18 |
chr15_+_31224460 | 0.99 |
ENSMUST00000044524.16
|
Dap
|
death-associated protein |
chr2_+_83554770 | 0.98 |
ENSMUST00000141725.3
|
Itgav
|
integrin alpha V |
chr18_+_36414122 | 0.97 |
ENSMUST00000051301.6
|
Pura
|
purine rich element binding protein A |
chr16_-_45544960 | 0.96 |
ENSMUST00000096057.5
|
Tagln3
|
transgelin 3 |
chr15_+_31225302 | 0.96 |
ENSMUST00000186425.7
|
Dap
|
death-associated protein |
chr3_-_54962899 | 0.95 |
ENSMUST00000199144.5
|
Ccna1
|
cyclin A1 |
chr10_-_107321938 | 0.94 |
ENSMUST00000000445.2
|
Myf5
|
myogenic factor 5 |
chr5_-_134776101 | 0.92 |
ENSMUST00000015138.13
|
Eln
|
elastin |
chr11_-_99412084 | 0.91 |
ENSMUST00000076948.2
|
Krt39
|
keratin 39 |
chr5_+_108842294 | 0.89 |
ENSMUST00000013633.12
|
Fgfrl1
|
fibroblast growth factor receptor-like 1 |
chr19_-_39637489 | 0.87 |
ENSMUST00000067328.7
|
Cyp2c67
|
cytochrome P450, family 2, subfamily c, polypeptide 67 |
chrM_+_8603 | 0.86 |
ENSMUST00000082409.1
|
mt-Co3
|
mitochondrially encoded cytochrome c oxidase III |
chr3_-_19319123 | 0.85 |
ENSMUST00000121951.2
|
Pde7a
|
phosphodiesterase 7A |
chr7_+_126550009 | 0.85 |
ENSMUST00000106332.3
|
Sez6l2
|
seizure related 6 homolog like 2 |
chr14_-_118289557 | 0.84 |
ENSMUST00000022725.4
|
Dct
|
dopachrome tautomerase |
chr14_-_64654397 | 0.84 |
ENSMUST00000210428.2
|
Msra
|
methionine sulfoxide reductase A |
chr9_+_55448432 | 0.84 |
ENSMUST00000034869.11
|
Isl2
|
insulin related protein 2 (islet 2) |
chr11_-_95966407 | 0.83 |
ENSMUST00000107686.8
ENSMUST00000107684.2 |
Atp5g1
|
ATP synthase, H+ transporting, mitochondrial F0 complex, subunit C1 (subunit 9) |
chr14_-_68771138 | 0.83 |
ENSMUST00000022640.8
|
Adam7
|
a disintegrin and metallopeptidase domain 7 |
chr16_-_48592319 | 0.83 |
ENSMUST00000239408.2
|
Trat1
|
T cell receptor associated transmembrane adaptor 1 |
chr15_+_39522905 | 0.82 |
ENSMUST00000226410.2
|
Rims2
|
regulating synaptic membrane exocytosis 2 |
chr8_-_85573489 | 0.82 |
ENSMUST00000003912.7
|
Calr
|
calreticulin |
chr15_-_13173736 | 0.82 |
ENSMUST00000036439.6
|
Cdh6
|
cadherin 6 |
chr7_+_143792455 | 0.81 |
ENSMUST00000239495.2
|
Shank2
|
SH3 and multiple ankyrin repeat domains 2 |
chr8_+_46111703 | 0.81 |
ENSMUST00000134675.8
ENSMUST00000139869.8 ENSMUST00000126067.8 |
Sorbs2
|
sorbin and SH3 domain containing 2 |
chr15_-_101801351 | 0.79 |
ENSMUST00000100179.2
|
Krt76
|
keratin 76 |
chr6_+_56901007 | 0.78 |
ENSMUST00000176838.2
|
Vmn1r4
|
vomeronasal 1 receptor 4 |
chr18_+_84106796 | 0.77 |
ENSMUST00000235383.2
|
Zadh2
|
zinc binding alcohol dehydrogenase, domain containing 2 |
chr9_+_107765320 | 0.77 |
ENSMUST00000191906.6
ENSMUST00000035202.4 |
Mon1a
|
MON1 homolog A, secretory traffciking associated |
chr9_+_32027335 | 0.77 |
ENSMUST00000174641.8
|
Arhgap32
|
Rho GTPase activating protein 32 |
chr11_-_99412162 | 0.76 |
ENSMUST00000107445.8
|
Krt39
|
keratin 39 |
chr6_-_84565613 | 0.75 |
ENSMUST00000204146.3
|
Cyp26b1
|
cytochrome P450, family 26, subfamily b, polypeptide 1 |
chr14_-_36820304 | 0.73 |
ENSMUST00000022337.11
|
Cdhr1
|
cadherin-related family member 1 |
chr5_+_42225303 | 0.72 |
ENSMUST00000087332.5
|
Gm16223
|
predicted gene 16223 |
chr2_+_83642910 | 0.72 |
ENSMUST00000051454.4
|
Fam171b
|
family with sequence similarity 171, member B |
chr7_+_65343156 | 0.72 |
ENSMUST00000032726.14
ENSMUST00000107495.5 ENSMUST00000143508.3 ENSMUST00000129166.3 ENSMUST00000206517.2 ENSMUST00000206837.2 ENSMUST00000206628.2 ENSMUST00000206361.2 |
Tm2d3
|
TM2 domain containing 3 |
chr18_+_9707595 | 0.72 |
ENSMUST00000234965.2
|
Colec12
|
collectin sub-family member 12 |
chr2_+_22959223 | 0.72 |
ENSMUST00000114523.10
|
Acbd5
|
acyl-Coenzyme A binding domain containing 5 |
chrM_+_7758 | 0.71 |
ENSMUST00000082407.1
|
mt-Atp8
|
mitochondrially encoded ATP synthase 8 |
chr10_-_8632519 | 0.70 |
ENSMUST00000212869.2
|
Sash1
|
SAM and SH3 domain containing 1 |
chr16_-_48592372 | 0.67 |
ENSMUST00000231701.3
|
Trat1
|
T cell receptor associated transmembrane adaptor 1 |
chr6_+_30541581 | 0.67 |
ENSMUST00000096066.5
|
Cpa2
|
carboxypeptidase A2, pancreatic |
chr5_-_86521273 | 0.67 |
ENSMUST00000031175.12
|
Tmprss11d
|
transmembrane protease, serine 11d |
chr2_+_59442378 | 0.66 |
ENSMUST00000112568.8
ENSMUST00000037526.11 |
Tanc1
|
tetratricopeptide repeat, ankyrin repeat and coiled-coil containing 1 |
chr6_-_147165623 | 0.66 |
ENSMUST00000052296.9
ENSMUST00000204197.2 |
Pthlh
|
parathyroid hormone-like peptide |
chr3_-_92031247 | 0.65 |
ENSMUST00000070284.4
|
Prr9
|
proline rich 9 |
chr18_+_56565188 | 0.65 |
ENSMUST00000070166.6
|
Gramd3
|
GRAM domain containing 3 |
chr15_+_100768776 | 0.64 |
ENSMUST00000108909.9
|
Scn8a
|
sodium channel, voltage-gated, type VIII, alpha |
chrX_+_113384297 | 0.63 |
ENSMUST00000133447.2
|
Klhl4
|
kelch-like 4 |
chr9_-_16289527 | 0.63 |
ENSMUST00000082170.6
|
Fat3
|
FAT atypical cadherin 3 |
chr2_+_83554741 | 0.62 |
ENSMUST00000028499.11
|
Itgav
|
integrin alpha V |
chr15_-_37458768 | 0.62 |
ENSMUST00000116445.9
|
Ncald
|
neurocalcin delta |
chr4_+_122730027 | 0.61 |
ENSMUST00000030412.11
ENSMUST00000121870.8 ENSMUST00000097902.5 |
Ppt1
|
palmitoyl-protein thioesterase 1 |
chr7_-_12829100 | 0.61 |
ENSMUST00000209822.3
ENSMUST00000235753.2 |
Vmn1r85
|
vomeronasal 1 receptor 85 |
chr6_+_40619913 | 0.61 |
ENSMUST00000238599.2
|
Mgam
|
maltase-glucoamylase |
chr12_-_83609217 | 0.61 |
ENSMUST00000222448.2
|
Zfyve1
|
zinc finger, FYVE domain containing 1 |
chr16_-_75563645 | 0.60 |
ENSMUST00000114244.2
ENSMUST00000046283.16 |
Hspa13
|
heat shock protein 70 family, member 13 |
chr8_+_84728123 | 0.60 |
ENSMUST00000060357.15
ENSMUST00000239176.2 |
1700067K01Rik
|
RIKEN cDNA 1700067K01 gene |
chr3_+_122213420 | 0.60 |
ENSMUST00000029766.9
|
Bcar3
|
breast cancer anti-estrogen resistance 3 |
chr17_-_29226700 | 0.59 |
ENSMUST00000233441.2
|
Stk38
|
serine/threonine kinase 38 |
chr4_-_14621669 | 0.58 |
ENSMUST00000143105.2
|
Slc26a7
|
solute carrier family 26, member 7 |
chr7_+_63835285 | 0.58 |
ENSMUST00000206263.2
ENSMUST00000206107.2 ENSMUST00000205731.2 ENSMUST00000206706.2 ENSMUST00000205690.2 |
Trpm1
|
transient receptor potential cation channel, subfamily M, member 1 |
chr15_-_96929086 | 0.58 |
ENSMUST00000230086.2
|
Slc38a4
|
solute carrier family 38, member 4 |
chr3_-_88194517 | 0.57 |
ENSMUST00000165196.8
|
Gm38392
|
predicted gene, 38392 |
chr9_+_121780054 | 0.56 |
ENSMUST00000043011.9
ENSMUST00000214536.3 ENSMUST00000215990.3 |
Gask1a
|
golgi associated kinase 1A |
chr12_-_56660054 | 0.56 |
ENSMUST00000072631.6
|
Nkx2-9
|
NK2 homeobox 9 |
chr10_-_12689345 | 0.55 |
ENSMUST00000217899.2
|
Utrn
|
utrophin |
chrM_+_7779 | 0.55 |
ENSMUST00000082408.1
|
mt-Atp6
|
mitochondrially encoded ATP synthase 6 |
chr5_+_14075281 | 0.55 |
ENSMUST00000073957.8
|
Sema3e
|
sema domain, immunoglobulin domain (Ig), short basic domain, secreted, (semaphorin) 3E |
chr1_-_14374794 | 0.54 |
ENSMUST00000190337.7
|
Eya1
|
EYA transcriptional coactivator and phosphatase 1 |
chr6_-_83654789 | 0.54 |
ENSMUST00000037882.8
|
Cd207
|
CD207 antigen |
chr2_+_27055245 | 0.53 |
ENSMUST00000000910.7
|
Dbh
|
dopamine beta hydroxylase |
chrX_-_99638466 | 0.53 |
ENSMUST00000053373.2
|
P2ry4
|
pyrimidinergic receptor P2Y, G-protein coupled, 4 |
chr4_-_14621497 | 0.53 |
ENSMUST00000149633.2
|
Slc26a7
|
solute carrier family 26, member 7 |
chr7_-_126183716 | 0.53 |
ENSMUST00000150311.8
|
Cln3
|
ceroid lipofuscinosis, neuronal 3, juvenile (Batten, Spielmeyer-Vogt disease) |
chr4_+_109835224 | 0.52 |
ENSMUST00000061187.4
|
Dmrta2
|
doublesex and mab-3 related transcription factor like family A2 |
chr11_+_99764215 | 0.52 |
ENSMUST00000093936.5
|
Krtap9-1
|
keratin associated protein 9-1 |
chr17_-_29226886 | 0.52 |
ENSMUST00000232723.2
|
Stk38
|
serine/threonine kinase 38 |
chr6_-_116084810 | 0.52 |
ENSMUST00000204353.3
|
Tmcc1
|
transmembrane and coiled coil domains 1 |
chr3_+_138019040 | 0.52 |
ENSMUST00000013455.13
ENSMUST00000106247.2 |
Adh6a
|
alcohol dehydrogenase 6A (class V) |
chr3_-_154036180 | 0.52 |
ENSMUST00000177846.8
|
Lhx8
|
LIM homeobox protein 8 |
chr4_-_14621805 | 0.52 |
ENSMUST00000042221.14
|
Slc26a7
|
solute carrier family 26, member 7 |
chr12_-_104439589 | 0.51 |
ENSMUST00000021513.6
|
Gsc
|
goosecoid homeobox |
chr14_-_80008745 | 0.51 |
ENSMUST00000039568.11
ENSMUST00000195355.2 |
Pcdh8
|
protocadherin 8 |
chr6_-_125357756 | 0.50 |
ENSMUST00000042647.7
|
Plekhg6
|
pleckstrin homology domain containing, family G (with RhoGef domain) member 6 |
chr2_-_45000250 | 0.50 |
ENSMUST00000201211.4
ENSMUST00000177302.8 |
Zeb2
|
zinc finger E-box binding homeobox 2 |
chr2_+_69727563 | 0.49 |
ENSMUST00000055758.16
ENSMUST00000112251.9 |
Ubr3
|
ubiquitin protein ligase E3 component n-recognin 3 |
chr2_-_5680801 | 0.49 |
ENSMUST00000114987.4
|
Camk1d
|
calcium/calmodulin-dependent protein kinase ID |
chr1_-_14374842 | 0.49 |
ENSMUST00000188857.7
ENSMUST00000185453.7 |
Eya1
|
EYA transcriptional coactivator and phosphatase 1 |
chr7_-_126183392 | 0.49 |
ENSMUST00000128970.8
ENSMUST00000116269.9 |
Cln3
|
ceroid lipofuscinosis, neuronal 3, juvenile (Batten, Spielmeyer-Vogt disease) |
chr18_-_81029986 | 0.49 |
ENSMUST00000057950.9
|
Sall3
|
spalt like transcription factor 3 |
chr2_-_77533596 | 0.49 |
ENSMUST00000171063.8
|
Zfp385b
|
zinc finger protein 385B |
chr2_+_69727599 | 0.49 |
ENSMUST00000131553.2
|
Ubr3
|
ubiquitin protein ligase E3 component n-recognin 3 |
chr5_-_23881353 | 0.48 |
ENSMUST00000198661.5
|
Srpk2
|
serine/arginine-rich protein specific kinase 2 |
chr16_+_44914397 | 0.48 |
ENSMUST00000061050.6
|
Ccdc80
|
coiled-coil domain containing 80 |
chr4_+_108576846 | 0.48 |
ENSMUST00000178992.2
|
3110021N24Rik
|
RIKEN cDNA 3110021N24 gene |
chrX_+_138464065 | 0.48 |
ENSMUST00000113027.8
|
Rnf128
|
ring finger protein 128 |
chr7_+_63835154 | 0.48 |
ENSMUST00000177102.8
|
Trpm1
|
transient receptor potential cation channel, subfamily M, member 1 |
chr14_+_79086492 | 0.48 |
ENSMUST00000040990.7
|
Vwa8
|
von Willebrand factor A domain containing 8 |
chr3_-_54962922 | 0.48 |
ENSMUST00000197238.5
|
Ccna1
|
cyclin A1 |
chr18_-_81029751 | 0.47 |
ENSMUST00000238808.2
|
Sall3
|
spalt like transcription factor 3 |
chr8_+_24159669 | 0.47 |
ENSMUST00000042352.11
ENSMUST00000207301.2 |
Zmat4
|
zinc finger, matrin type 4 |
chr6_+_114435480 | 0.47 |
ENSMUST00000160780.2
|
Hrh1
|
histamine receptor H1 |
chrX_-_142716085 | 0.47 |
ENSMUST00000087313.10
|
Dcx
|
doublecortin |
chr12_-_57592907 | 0.46 |
ENSMUST00000044380.8
|
Foxa1
|
forkhead box A1 |
chr16_-_93726399 | 0.46 |
ENSMUST00000177648.8
ENSMUST00000142083.2 |
Cldn14
|
claudin 14 |
chr9_-_96513529 | 0.46 |
ENSMUST00000034984.8
|
Rasa2
|
RAS p21 protein activator 2 |
chr2_+_127696548 | 0.46 |
ENSMUST00000028859.8
|
Acoxl
|
acyl-Coenzyme A oxidase-like |
chr11_-_99979052 | 0.46 |
ENSMUST00000107419.2
|
Krt32
|
keratin 32 |
chr14_+_54183465 | 0.45 |
ENSMUST00000197130.5
ENSMUST00000103677.3 |
Trdv2-1
|
T cell receptor delta variable 2-1 |
chr15_+_92495007 | 0.44 |
ENSMUST00000035399.10
|
Pdzrn4
|
PDZ domain containing RING finger 4 |
chr10_+_68987257 | 0.44 |
ENSMUST00000167286.8
|
Rhobtb1
|
Rho-related BTB domain containing 1 |
chr10_-_43934774 | 0.43 |
ENSMUST00000239010.2
|
Crybg1
|
crystallin beta-gamma domain containing 1 |
chr6_-_93769426 | 0.42 |
ENSMUST00000204788.2
|
Magi1
|
membrane associated guanylate kinase, WW and PDZ domain containing 1 |
chr9_+_123195986 | 0.42 |
ENSMUST00000038863.9
ENSMUST00000216843.2 |
Lars2
|
leucyl-tRNA synthetase, mitochondrial |
chr18_-_38336893 | 0.42 |
ENSMUST00000194312.2
|
Pcdh1
|
protocadherin 1 |
chr14_-_109151590 | 0.42 |
ENSMUST00000100322.4
|
Slitrk1
|
SLIT and NTRK-like family, member 1 |
chr6_-_41752111 | 0.42 |
ENSMUST00000214976.3
|
Olfr459
|
olfactory receptor 459 |
chr1_+_104696235 | 0.42 |
ENSMUST00000062528.9
|
Cdh20
|
cadherin 20 |
chr12_+_76580386 | 0.42 |
ENSMUST00000219063.2
|
Plekhg3
|
pleckstrin homology domain containing, family G (with RhoGef domain) member 3 |
chr15_-_8739893 | 0.41 |
ENSMUST00000157065.2
|
Slc1a3
|
solute carrier family 1 (glial high affinity glutamate transporter), member 3 |
chr13_-_103042294 | 0.41 |
ENSMUST00000167462.8
|
Mast4
|
microtubule associated serine/threonine kinase family member 4 |
chr8_-_62355690 | 0.41 |
ENSMUST00000121785.9
ENSMUST00000034057.14 |
Palld
|
palladin, cytoskeletal associated protein |
chr3_-_88368489 | 0.41 |
ENSMUST00000166237.8
|
Sema4a
|
sema domain, immunoglobulin domain (Ig), transmembrane domain (TM) and short cytoplasmic domain, (semaphorin) 4A |
chr11_+_67689094 | 0.41 |
ENSMUST00000168612.8
|
Dhrs7c
|
dehydrogenase/reductase (SDR family) member 7C |
chr8_+_4288815 | 0.40 |
ENSMUST00000003027.14
ENSMUST00000110999.8 |
Map2k7
|
mitogen-activated protein kinase kinase 7 |
chr7_-_90125178 | 0.40 |
ENSMUST00000032843.9
|
Tmem126b
|
transmembrane protein 126B |
chr15_+_21111428 | 0.40 |
ENSMUST00000075132.8
|
Cdh12
|
cadherin 12 |
chr14_-_63221950 | 0.39 |
ENSMUST00000100493.3
|
Defb48
|
defensin beta 48 |
chrX_+_8233217 | 0.39 |
ENSMUST00000115584.2
|
Ssxb9
|
synovial sarcoma, X member B9 |
chr11_+_67090878 | 0.39 |
ENSMUST00000124516.8
ENSMUST00000018637.15 ENSMUST00000129018.8 |
Myh1
|
myosin, heavy polypeptide 1, skeletal muscle, adult |
chr1_+_88234454 | 0.39 |
ENSMUST00000040210.14
|
Trpm8
|
transient receptor potential cation channel, subfamily M, member 8 |
chr3_+_93301003 | 0.39 |
ENSMUST00000045912.3
|
Rptn
|
repetin |
chr1_-_14380418 | 0.39 |
ENSMUST00000027066.13
ENSMUST00000168081.9 |
Eya1
|
EYA transcriptional coactivator and phosphatase 1 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.7 | 2.8 | GO:0015855 | nucleobase transport(GO:0015851) pyrimidine nucleobase transport(GO:0015855) |
0.7 | 2.0 | GO:2000536 | negative regulation of entry of bacterium into host cell(GO:2000536) |
0.7 | 5.9 | GO:0045919 | positive regulation of cytolysis(GO:0045919) |
0.6 | 1.7 | GO:2001055 | positive regulation of mesenchymal cell apoptotic process(GO:2001055) |
0.5 | 1.4 | GO:1903920 | positive regulation of actin filament severing(GO:1903920) |
0.4 | 6.0 | GO:0015747 | urate transport(GO:0015747) |
0.4 | 3.5 | GO:2000427 | positive regulation of apoptotic cell clearance(GO:2000427) |
0.4 | 1.2 | GO:0001982 | baroreceptor response to decreased systemic arterial blood pressure(GO:0001982) |
0.4 | 2.5 | GO:1901509 | regulation of endothelial tube morphogenesis(GO:1901509) |
0.3 | 18.4 | GO:0007339 | binding of sperm to zona pellucida(GO:0007339) |
0.3 | 2.0 | GO:0014846 | esophagus smooth muscle contraction(GO:0014846) |
0.3 | 2.8 | GO:0046874 | quinolinate metabolic process(GO:0046874) |
0.3 | 1.2 | GO:0019343 | cysteine biosynthetic process via cystathionine(GO:0019343) |
0.3 | 0.8 | GO:0021524 | visceral motor neuron differentiation(GO:0021524) |
0.3 | 0.8 | GO:0002396 | MHC protein complex assembly(GO:0002396) peptide antigen assembly with MHC protein complex(GO:0002501) |
0.3 | 1.8 | GO:0000103 | sulfate assimilation(GO:0000103) |
0.2 | 1.5 | GO:0001920 | negative regulation of receptor recycling(GO:0001920) |
0.2 | 2.2 | GO:0006572 | tyrosine catabolic process(GO:0006572) |
0.2 | 1.0 | GO:0071596 | ubiquitin-dependent protein catabolic process via the N-end rule pathway(GO:0071596) |
0.2 | 2.8 | GO:0052697 | flavonoid glucuronidation(GO:0052696) xenobiotic glucuronidation(GO:0052697) |
0.2 | 0.7 | GO:0060618 | nipple development(GO:0060618) |
0.2 | 0.6 | GO:0061075 | cerebral cortex GABAergic interneuron fate commitment(GO:0021893) positive regulation of neural retina development(GO:0061075) positive regulation of retina development in camera-type eye(GO:1902868) positive regulation of amacrine cell differentiation(GO:1902871) |
0.2 | 1.0 | GO:0035752 | lysosomal lumen pH elevation(GO:0035752) |
0.2 | 1.8 | GO:0006682 | galactosylceramide biosynthetic process(GO:0006682) galactolipid biosynthetic process(GO:0019375) |
0.2 | 0.6 | GO:0006583 | melanin biosynthetic process from tyrosine(GO:0006583) |
0.2 | 0.8 | GO:2001035 | tongue muscle cell differentiation(GO:0035981) positive regulation of skeletal muscle fiber differentiation(GO:1902811) regulation of tongue muscle cell differentiation(GO:2001035) positive regulation of tongue muscle cell differentiation(GO:2001037) |
0.2 | 1.5 | GO:0070562 | regulation of vitamin D receptor signaling pathway(GO:0070562) |
0.2 | 2.0 | GO:0030242 | pexophagy(GO:0030242) |
0.2 | 1.6 | GO:0019532 | oxalate transport(GO:0019532) |
0.2 | 0.5 | GO:0046333 | octopamine biosynthetic process(GO:0006589) octopamine metabolic process(GO:0046333) |
0.2 | 1.0 | GO:0034334 | adherens junction maintenance(GO:0034334) |
0.2 | 1.9 | GO:0072513 | positive regulation of secondary heart field cardioblast proliferation(GO:0072513) |
0.2 | 3.7 | GO:0006120 | mitochondrial electron transport, NADH to ubiquinone(GO:0006120) |
0.2 | 1.6 | GO:0051596 | methylglyoxal catabolic process to D-lactate via S-lactoyl-glutathione(GO:0019243) methylglyoxal catabolic process(GO:0051596) methylglyoxal catabolic process to lactate(GO:0061727) |
0.2 | 0.5 | GO:0061144 | alveolar secondary septum development(GO:0061144) |
0.1 | 0.6 | GO:0072488 | ammonium transmembrane transport(GO:0072488) |
0.1 | 0.4 | GO:0006429 | leucyl-tRNA aminoacylation(GO:0006429) |
0.1 | 0.7 | GO:1902498 | regulation of protein autoubiquitination(GO:1902498) |
0.1 | 1.3 | GO:0086023 | adrenergic receptor signaling pathway involved in heart process(GO:0086023) |
0.1 | 0.6 | GO:0060414 | aorta smooth muscle tissue morphogenesis(GO:0060414) |
0.1 | 0.9 | GO:0048743 | positive regulation of skeletal muscle fiber development(GO:0048743) |
0.1 | 1.0 | GO:0021891 | olfactory bulb interneuron development(GO:0021891) |
0.1 | 0.3 | GO:0035934 | corticosterone secretion(GO:0035934) |
0.1 | 0.6 | GO:0098734 | protein depalmitoylation(GO:0002084) macromolecule depalmitoylation(GO:0098734) |
0.1 | 1.3 | GO:0006957 | complement activation, alternative pathway(GO:0006957) |
0.1 | 0.5 | GO:0035063 | nuclear speck organization(GO:0035063) |
0.1 | 5.6 | GO:0034198 | cellular response to amino acid starvation(GO:0034198) |
0.1 | 2.5 | GO:0001886 | endothelial cell morphogenesis(GO:0001886) |
0.1 | 0.4 | GO:0003221 | right ventricular cardiac muscle tissue morphogenesis(GO:0003221) |
0.1 | 4.4 | GO:0042773 | ATP synthesis coupled electron transport(GO:0042773) |
0.1 | 0.3 | GO:0090362 | positive regulation of platelet-derived growth factor production(GO:0090362) |
0.1 | 0.6 | GO:0009449 | gamma-aminobutyric acid biosynthetic process(GO:0009449) D-aspartate transport(GO:0070777) D-aspartate import(GO:0070779) |
0.1 | 1.0 | GO:0006268 | DNA unwinding involved in DNA replication(GO:0006268) |
0.1 | 0.5 | GO:0007527 | adult somatic muscle development(GO:0007527) |
0.1 | 0.3 | GO:0002302 | CD8-positive, alpha-beta T cell differentiation involved in immune response(GO:0002302) |
0.1 | 0.5 | GO:0071421 | manganese ion transmembrane transport(GO:0071421) |
0.1 | 0.4 | GO:0002023 | reduction of food intake in response to dietary excess(GO:0002023) positive regulation of somatostatin secretion(GO:0090274) |
0.1 | 0.8 | GO:0097151 | positive regulation of inhibitory postsynaptic potential(GO:0097151) |
0.1 | 0.2 | GO:0002014 | vasoconstriction of artery involved in ischemic response to lowering of systemic arterial blood pressure(GO:0002014) |
0.1 | 0.3 | GO:0051919 | positive regulation of fibrinolysis(GO:0051919) |
0.1 | 2.1 | GO:0015985 | energy coupled proton transport, down electrochemical gradient(GO:0015985) ATP synthesis coupled proton transport(GO:0015986) |
0.1 | 0.3 | GO:0043328 | protein targeting to vacuole involved in ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway(GO:0043328) |
0.1 | 1.8 | GO:0045603 | positive regulation of endothelial cell differentiation(GO:0045603) |
0.1 | 0.3 | GO:0001550 | ovarian cumulus expansion(GO:0001550) fused antrum stage(GO:0048165) |
0.1 | 0.2 | GO:2000292 | negative regulation of eating behavior(GO:1903999) regulation of defecation(GO:2000292) negative regulation of defecation(GO:2000293) |
0.1 | 0.1 | GO:0019858 | cytosine metabolic process(GO:0019858) |
0.1 | 2.2 | GO:0090036 | regulation of protein kinase C signaling(GO:0090036) |
0.1 | 0.3 | GO:0021889 | olfactory bulb interneuron differentiation(GO:0021889) |
0.1 | 0.2 | GO:0043133 | hindgut contraction(GO:0043133) regulation of hindgut contraction(GO:0043134) positive regulation of hindgut contraction(GO:0060450) |
0.1 | 0.7 | GO:0060355 | positive regulation of cell adhesion molecule production(GO:0060355) |
0.1 | 2.1 | GO:0016339 | calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0016339) |
0.1 | 0.7 | GO:0048672 | positive regulation of collateral sprouting(GO:0048672) |
0.1 | 0.5 | GO:0060267 | positive regulation of respiratory burst(GO:0060267) |
0.1 | 0.2 | GO:0014732 | skeletal muscle atrophy(GO:0014732) |
0.1 | 0.3 | GO:1903860 | negative regulation of dendrite extension(GO:1903860) |
0.1 | 0.1 | GO:0021759 | globus pallidus development(GO:0021759) |
0.1 | 0.2 | GO:1900739 | regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway(GO:1900739) positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway(GO:1900740) |
0.1 | 0.3 | GO:0006931 | substrate-dependent cell migration, cell attachment to substrate(GO:0006931) |
0.0 | 0.4 | GO:0032020 | ISG15-protein conjugation(GO:0032020) |
0.0 | 1.1 | GO:0046548 | retinal rod cell development(GO:0046548) |
0.0 | 0.3 | GO:0042706 | eye photoreceptor cell fate commitment(GO:0042706) photoreceptor cell fate commitment(GO:0046552) |
0.0 | 2.5 | GO:0050919 | negative chemotaxis(GO:0050919) |
0.0 | 0.1 | GO:0032416 | negative regulation of sodium:proton antiporter activity(GO:0032416) |
0.0 | 0.9 | GO:0040037 | negative regulation of fibroblast growth factor receptor signaling pathway(GO:0040037) |
0.0 | 0.3 | GO:0032049 | cardiolipin biosynthetic process(GO:0032049) |
0.0 | 0.3 | GO:0001712 | ectodermal cell fate commitment(GO:0001712) |
0.0 | 0.2 | GO:0072092 | ureteric bud invasion(GO:0072092) |
0.0 | 0.8 | GO:0048733 | sebaceous gland development(GO:0048733) |
0.0 | 0.8 | GO:0036342 | post-anal tail morphogenesis(GO:0036342) |
0.0 | 0.1 | GO:0071879 | positive regulation of adrenergic receptor signaling pathway(GO:0071879) negative regulation of locomotion involved in locomotory behavior(GO:0090327) |
0.0 | 0.2 | GO:0099566 | regulation of postsynaptic cytosolic calcium ion concentration(GO:0099566) |
0.0 | 0.2 | GO:0038128 | ERBB2 signaling pathway(GO:0038128) |
0.0 | 0.2 | GO:0006538 | glutamate catabolic process(GO:0006538) |
0.0 | 0.2 | GO:0007262 | STAT protein import into nucleus(GO:0007262) |
0.0 | 1.2 | GO:0031069 | hair follicle morphogenesis(GO:0031069) |
0.0 | 0.1 | GO:0060729 | intestinal epithelial structure maintenance(GO:0060729) |
0.0 | 0.3 | GO:1904861 | excitatory synapse assembly(GO:1904861) |
0.0 | 0.1 | GO:0009946 | proximal/distal axis specification(GO:0009946) |
0.0 | 0.2 | GO:0021559 | trigeminal nerve development(GO:0021559) |
0.0 | 3.5 | GO:0007156 | homophilic cell adhesion via plasma membrane adhesion molecules(GO:0007156) |
0.0 | 0.3 | GO:0009249 | protein lipoylation(GO:0009249) |
0.0 | 0.5 | GO:2000671 | regulation of motor neuron apoptotic process(GO:2000671) |
0.0 | 0.6 | GO:0015701 | bicarbonate transport(GO:0015701) |
0.0 | 0.4 | GO:0003334 | keratinocyte development(GO:0003334) |
0.0 | 0.8 | GO:0071625 | positive regulation of synaptic transmission, glutamatergic(GO:0051968) vocalization behavior(GO:0071625) |
0.0 | 1.3 | GO:0032728 | positive regulation of interferon-beta production(GO:0032728) |
0.0 | 0.9 | GO:0019373 | epoxygenase P450 pathway(GO:0019373) |
0.0 | 0.2 | GO:0035887 | aortic smooth muscle cell differentiation(GO:0035887) |
0.0 | 0.1 | GO:0051799 | negative regulation of hair follicle development(GO:0051799) |
0.0 | 0.1 | GO:0060060 | post-embryonic retina morphogenesis in camera-type eye(GO:0060060) |
0.0 | 0.6 | GO:0022904 | respiratory electron transport chain(GO:0022904) |
0.0 | 0.2 | GO:0050955 | thermoception(GO:0050955) |
0.0 | 0.1 | GO:0061153 | trachea submucosa development(GO:0061152) trachea gland development(GO:0061153) |
0.0 | 0.4 | GO:0006488 | dolichol-linked oligosaccharide biosynthetic process(GO:0006488) |
0.0 | 0.1 | GO:1905053 | regulation of base-excision repair(GO:1905051) positive regulation of base-excision repair(GO:1905053) |
0.0 | 0.7 | GO:0097062 | dendritic spine maintenance(GO:0097062) |
0.0 | 0.1 | GO:0021553 | olfactory nerve development(GO:0021553) olfactory nerve morphogenesis(GO:0021627) olfactory nerve structural organization(GO:0021629) |
0.0 | 0.5 | GO:2000114 | regulation of establishment of cell polarity(GO:2000114) |
0.0 | 0.2 | GO:2001269 | positive regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:2001269) |
0.0 | 1.0 | GO:0071385 | cellular response to glucocorticoid stimulus(GO:0071385) |
0.0 | 0.6 | GO:0002089 | lens morphogenesis in camera-type eye(GO:0002089) |
0.0 | 0.3 | GO:0031573 | intra-S DNA damage checkpoint(GO:0031573) |
0.0 | 0.3 | GO:0016554 | cytidine to uridine editing(GO:0016554) |
0.0 | 0.1 | GO:0071372 | cellular response to follicle-stimulating hormone stimulus(GO:0071372) |
0.0 | 0.5 | GO:0023019 | signal transduction involved in regulation of gene expression(GO:0023019) |
0.0 | 0.4 | GO:0021796 | cerebral cortex regionalization(GO:0021796) |
0.0 | 0.3 | GO:0033327 | Leydig cell differentiation(GO:0033327) |
0.0 | 0.3 | GO:0051645 | Golgi localization(GO:0051645) |
0.0 | 0.8 | GO:0018149 | peptide cross-linking(GO:0018149) |
0.0 | 0.2 | GO:0072378 | blood coagulation, fibrin clot formation(GO:0072378) |
0.0 | 0.1 | GO:0060672 | epithelial cell differentiation involved in embryonic placenta development(GO:0060671) epithelial cell morphogenesis involved in placental branching(GO:0060672) |
0.0 | 0.9 | GO:0045599 | negative regulation of fat cell differentiation(GO:0045599) |
0.0 | 0.1 | GO:0005513 | detection of calcium ion(GO:0005513) |
0.0 | 0.5 | GO:0021884 | forebrain neuron development(GO:0021884) |
0.0 | 0.3 | GO:0030150 | protein import into mitochondrial matrix(GO:0030150) |
0.0 | 0.4 | GO:0046069 | cGMP catabolic process(GO:0046069) |
0.0 | 0.2 | GO:0035729 | cellular response to hepatocyte growth factor stimulus(GO:0035729) |
0.0 | 0.9 | GO:0003298 | physiological muscle hypertrophy(GO:0003298) physiological cardiac muscle hypertrophy(GO:0003301) cell growth involved in cardiac muscle cell development(GO:0061049) |
0.0 | 0.1 | GO:1903566 | positive regulation of protein localization to cilium(GO:1903566) |
0.0 | 0.1 | GO:0009216 | purine deoxyribonucleoside diphosphate metabolic process(GO:0009182) purine deoxyribonucleoside triphosphate biosynthetic process(GO:0009216) dGDP metabolic process(GO:0046066) |
0.0 | 1.8 | GO:0009267 | cellular response to starvation(GO:0009267) |
0.0 | 0.2 | GO:0042135 | neurotransmitter catabolic process(GO:0042135) |
0.0 | 0.2 | GO:0098719 | sodium ion import across plasma membrane(GO:0098719) sodium ion import into cell(GO:1990118) |
0.0 | 1.4 | GO:0019236 | response to pheromone(GO:0019236) |
0.0 | 0.5 | GO:0042036 | negative regulation of cytokine biosynthetic process(GO:0042036) |
0.0 | 0.1 | GO:0010793 | regulation of histone H3-K36 methylation(GO:0000414) regulation of mRNA export from nucleus(GO:0010793) |
0.0 | 0.1 | GO:0032926 | negative regulation of activin receptor signaling pathway(GO:0032926) |
0.0 | 0.3 | GO:0097094 | craniofacial suture morphogenesis(GO:0097094) |
0.0 | 0.4 | GO:0009299 | mRNA transcription(GO:0009299) |
0.0 | 0.1 | GO:0036158 | outer dynein arm assembly(GO:0036158) |
0.0 | 0.6 | GO:0007628 | adult walking behavior(GO:0007628) |
0.0 | 0.2 | GO:0097186 | amelogenesis(GO:0097186) |
0.0 | 0.2 | GO:0031424 | keratinization(GO:0031424) |
0.0 | 0.3 | GO:0033194 | response to hydroperoxide(GO:0033194) |
0.0 | 0.2 | GO:0036159 | inner dynein arm assembly(GO:0036159) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.5 | 2.0 | GO:0034686 | integrin alphav-beta3 complex(GO:0034683) integrin alphav-beta8 complex(GO:0034686) |
0.4 | 1.6 | GO:0097123 | cyclin A1-CDK2 complex(GO:0097123) |
0.3 | 0.9 | GO:0016014 | dystrobrevin complex(GO:0016014) |
0.2 | 1.1 | GO:0035841 | new growing cell tip(GO:0035841) |
0.2 | 1.5 | GO:0005726 | perichromatin fibrils(GO:0005726) |
0.2 | 0.5 | GO:0034774 | secretory granule lumen(GO:0034774) cytoplasmic membrane-bounded vesicle lumen(GO:0060205) |
0.1 | 1.3 | GO:0005579 | membrane attack complex(GO:0005579) |
0.1 | 0.4 | GO:0014801 | longitudinal sarcoplasmic reticulum(GO:0014801) |
0.1 | 2.1 | GO:0045263 | proton-transporting ATP synthase complex, coupling factor F(o)(GO:0045263) |
0.1 | 0.6 | GO:0071953 | elastic fiber(GO:0071953) |
0.1 | 0.6 | GO:0097629 | extrinsic component of omegasome membrane(GO:0097629) |
0.1 | 0.3 | GO:0001405 | presequence translocase-associated import motor(GO:0001405) |
0.1 | 9.6 | GO:0070469 | respiratory chain(GO:0070469) |
0.1 | 0.8 | GO:0042824 | MHC class I peptide loading complex(GO:0042824) |
0.1 | 0.3 | GO:0000814 | ESCRT II complex(GO:0000814) |
0.1 | 2.9 | GO:0080008 | Cul4-RING E3 ubiquitin ligase complex(GO:0080008) |
0.1 | 1.0 | GO:0005662 | DNA replication factor A complex(GO:0005662) |
0.1 | 0.5 | GO:0001674 | female germ cell nucleus(GO:0001674) |
0.1 | 0.8 | GO:0005883 | neurofilament(GO:0005883) |
0.0 | 5.5 | GO:0005882 | intermediate filament(GO:0005882) |
0.0 | 1.5 | GO:0042101 | T cell receptor complex(GO:0042101) |
0.0 | 0.7 | GO:0042622 | photoreceptor outer segment membrane(GO:0042622) |
0.0 | 0.3 | GO:0000172 | ribonuclease MRP complex(GO:0000172) |
0.0 | 1.2 | GO:0033017 | sarcoplasmic reticulum membrane(GO:0033017) |
0.0 | 1.1 | GO:0001533 | cornified envelope(GO:0001533) |
0.0 | 0.2 | GO:0070695 | FHF complex(GO:0070695) |
0.0 | 0.2 | GO:0033588 | Elongator holoenzyme complex(GO:0033588) |
0.0 | 0.6 | GO:0001518 | voltage-gated sodium channel complex(GO:0001518) |
0.0 | 0.2 | GO:0005577 | fibrinogen complex(GO:0005577) |
0.0 | 0.8 | GO:0005614 | interstitial matrix(GO:0005614) |
0.0 | 7.0 | GO:0072562 | blood microparticle(GO:0072562) |
0.0 | 0.7 | GO:0016010 | dystrophin-associated glycoprotein complex(GO:0016010) glycoprotein complex(GO:0090665) |
0.0 | 0.5 | GO:0031235 | intrinsic component of the cytoplasmic side of the plasma membrane(GO:0031235) |
0.0 | 0.9 | GO:0060077 | inhibitory synapse(GO:0060077) |
0.0 | 0.4 | GO:0071437 | invadopodium(GO:0071437) |
0.0 | 0.6 | GO:0048770 | melanosome(GO:0042470) pigment granule(GO:0048770) |
0.0 | 0.7 | GO:0005581 | collagen trimer(GO:0005581) |
0.0 | 30.0 | GO:0005615 | extracellular space(GO:0005615) |
0.0 | 0.1 | GO:0030015 | CCR4-NOT core complex(GO:0030015) |
0.0 | 1.7 | GO:0044291 | cell-cell contact zone(GO:0044291) |
0.0 | 0.2 | GO:0036156 | inner dynein arm(GO:0036156) |
0.0 | 3.0 | GO:0042579 | peroxisome(GO:0005777) microbody(GO:0042579) |
0.0 | 0.2 | GO:0043083 | synaptic cleft(GO:0043083) |
0.0 | 1.0 | GO:0005776 | autophagosome(GO:0005776) |
0.0 | 0.6 | GO:0032154 | cleavage furrow(GO:0032154) cell surface furrow(GO:0097610) |
0.0 | 0.7 | GO:0031594 | neuromuscular junction(GO:0031594) |
0.0 | 0.4 | GO:0002102 | podosome(GO:0002102) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.8 | 5.9 | GO:0001851 | complement component C3b binding(GO:0001851) |
0.8 | 18.4 | GO:0008191 | metalloendopeptidase inhibitor activity(GO:0008191) |
0.6 | 2.8 | GO:0005350 | purine nucleobase transmembrane transporter activity(GO:0005345) pyrimidine nucleobase transmembrane transporter activity(GO:0005350) nucleobase transmembrane transporter activity(GO:0015205) glycerol channel activity(GO:0015254) |
0.5 | 1.8 | GO:0047275 | glucosaminylgalactosylglucosylceramide beta-galactosyltransferase activity(GO:0047275) |
0.4 | 1.8 | GO:0004062 | aryl sulfotransferase activity(GO:0004062) |
0.4 | 6.0 | GO:1901702 | urate transmembrane transporter activity(GO:0015143) salt transmembrane transporter activity(GO:1901702) |
0.3 | 1.0 | GO:0008431 | vitamin E binding(GO:0008431) |
0.3 | 0.9 | GO:0001571 | non-tyrosine kinase fibroblast growth factor receptor activity(GO:0001571) |
0.3 | 9.1 | GO:0050136 | NADH dehydrogenase (ubiquinone) activity(GO:0008137) NADH dehydrogenase (quinone) activity(GO:0050136) |
0.3 | 1.2 | GO:0004937 | alpha1-adrenergic receptor activity(GO:0004937) |
0.3 | 6.1 | GO:0070513 | death domain binding(GO:0070513) |
0.3 | 2.0 | GO:0008449 | N-acetylglucosamine-6-sulfatase activity(GO:0008449) |
0.2 | 1.0 | GO:0032422 | purine-rich negative regulatory element binding(GO:0032422) |
0.2 | 2.0 | GO:1990430 | extracellular matrix protein binding(GO:1990430) |
0.2 | 1.5 | GO:0034056 | estrogen response element binding(GO:0034056) |
0.2 | 0.8 | GO:0008113 | peptide-methionine (S)-S-oxide reductase activity(GO:0008113) |
0.2 | 1.6 | GO:0004416 | hydroxyacylglutathione hydrolase activity(GO:0004416) |
0.2 | 1.4 | GO:0061629 | RNA polymerase II sequence-specific DNA binding transcription factor binding(GO:0061629) |
0.2 | 0.8 | GO:0047522 | 13-prostaglandin reductase activity(GO:0036132) 15-oxoprostaglandin 13-oxidase activity(GO:0047522) |
0.2 | 1.3 | GO:0042030 | ATPase inhibitor activity(GO:0042030) |
0.2 | 0.5 | GO:0004500 | dopamine beta-monooxygenase activity(GO:0004500) |
0.2 | 0.5 | GO:0045030 | UTP-activated nucleotide receptor activity(GO:0045030) |
0.1 | 5.0 | GO:0016702 | oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen(GO:0016702) |
0.1 | 0.4 | GO:0004823 | leucine-tRNA ligase activity(GO:0004823) |
0.1 | 5.4 | GO:0015020 | glucuronosyltransferase activity(GO:0015020) |
0.1 | 0.8 | GO:0008401 | retinoic acid 4-hydroxylase activity(GO:0008401) |
0.1 | 0.5 | GO:0051381 | histamine binding(GO:0051381) |
0.1 | 2.5 | GO:0044548 | S100 protein binding(GO:0044548) |
0.1 | 2.7 | GO:0004745 | retinol dehydrogenase activity(GO:0004745) |
0.1 | 0.6 | GO:0032450 | maltose alpha-glucosidase activity(GO:0032450) |
0.1 | 0.6 | GO:0015501 | glutamate:sodium symporter activity(GO:0015501) |
0.1 | 1.6 | GO:0019531 | oxalate transmembrane transporter activity(GO:0019531) |
0.1 | 0.3 | GO:0000171 | ribonuclease MRP activity(GO:0000171) |
0.1 | 0.5 | GO:0008545 | JUN kinase kinase activity(GO:0008545) |
0.1 | 1.2 | GO:0016846 | carbon-sulfur lyase activity(GO:0016846) |
0.1 | 0.2 | GO:0070698 | type I activin receptor binding(GO:0070698) |
0.1 | 0.6 | GO:0098599 | palmitoyl-(protein) hydrolase activity(GO:0008474) palmitoyl hydrolase activity(GO:0098599) |
0.1 | 1.3 | GO:0001848 | complement binding(GO:0001848) |
0.1 | 0.4 | GO:0042296 | ISG15 transferase activity(GO:0042296) |
0.1 | 0.2 | GO:0000822 | inositol hexakisphosphate binding(GO:0000822) |
0.1 | 2.0 | GO:0000062 | fatty-acyl-CoA binding(GO:0000062) |
0.0 | 0.8 | GO:0016863 | intramolecular oxidoreductase activity, transposing C=C bonds(GO:0016863) |
0.0 | 0.2 | GO:0004652 | polynucleotide adenylyltransferase activity(GO:0004652) |
0.0 | 1.3 | GO:0004129 | cytochrome-c oxidase activity(GO:0004129) heme-copper terminal oxidase activity(GO:0015002) oxidoreductase activity, acting on a heme group of donors, oxygen as acceptor(GO:0016676) |
0.0 | 0.3 | GO:0004966 | galanin receptor activity(GO:0004966) |
0.0 | 0.8 | GO:0046933 | proton-transporting ATP synthase activity, rotational mechanism(GO:0046933) |
0.0 | 0.4 | GO:0004687 | myosin light chain kinase activity(GO:0004687) |
0.0 | 0.3 | GO:0005025 | transforming growth factor beta receptor activity, type I(GO:0005025) |
0.0 | 0.4 | GO:0048101 | calmodulin-dependent cyclic-nucleotide phosphodiesterase activity(GO:0004117) calcium- and calmodulin-regulated 3',5'-cyclic-GMP phosphodiesterase activity(GO:0048101) |
0.0 | 0.1 | GO:0001591 | dopamine neurotransmitter receptor activity, coupled via Gi/Go(GO:0001591) |
0.0 | 2.1 | GO:0005160 | transforming growth factor beta receptor binding(GO:0005160) |
0.0 | 0.7 | GO:0038187 | signaling pattern recognition receptor activity(GO:0008329) pattern recognition receptor activity(GO:0038187) |
0.0 | 1.1 | GO:0031435 | mitogen-activated protein kinase kinase kinase binding(GO:0031435) |
0.0 | 0.1 | GO:0070699 | type II activin receptor binding(GO:0070699) |
0.0 | 0.5 | GO:0038191 | neuropilin binding(GO:0038191) |
0.0 | 0.1 | GO:0016499 | orexin receptor activity(GO:0016499) |
0.0 | 0.2 | GO:0005000 | vasopressin receptor activity(GO:0005000) |
0.0 | 0.3 | GO:0000774 | adenyl-nucleotide exchange factor activity(GO:0000774) |
0.0 | 0.1 | GO:0031699 | beta-3 adrenergic receptor binding(GO:0031699) |
0.0 | 0.6 | GO:0008510 | sodium:bicarbonate symporter activity(GO:0008510) |
0.0 | 0.1 | GO:0015319 | sodium:inorganic phosphate symporter activity(GO:0015319) |
0.0 | 0.2 | GO:0004351 | glutamate decarboxylase activity(GO:0004351) |
0.0 | 0.9 | GO:0008392 | arachidonic acid epoxygenase activity(GO:0008392) |
0.0 | 0.7 | GO:0051428 | peptide hormone receptor binding(GO:0051428) |
0.0 | 0.3 | GO:0005176 | ErbB-2 class receptor binding(GO:0005176) |
0.0 | 0.2 | GO:0099583 | neurotransmitter receptor activity involved in regulation of postsynaptic cytosolic calcium ion concentration(GO:0099583) |
0.0 | 0.7 | GO:0001968 | fibronectin binding(GO:0001968) |
0.0 | 0.2 | GO:0005436 | sodium:phosphate symporter activity(GO:0005436) |
0.0 | 0.3 | GO:0003956 | NAD(P)+-protein-arginine ADP-ribosyltransferase activity(GO:0003956) |
0.0 | 0.8 | GO:0008157 | protein phosphatase 1 binding(GO:0008157) |
0.0 | 0.6 | GO:0005545 | 1-phosphatidylinositol binding(GO:0005545) |
0.0 | 0.3 | GO:0050692 | DBD domain binding(GO:0050692) |
0.0 | 0.6 | GO:0005248 | voltage-gated sodium channel activity(GO:0005248) |
0.0 | 0.1 | GO:0070579 | methylcytosine dioxygenase activity(GO:0070579) |
0.0 | 0.2 | GO:0015386 | potassium:proton antiporter activity(GO:0015386) |
0.0 | 2.3 | GO:0004540 | ribonuclease activity(GO:0004540) |
0.0 | 3.7 | GO:0004252 | serine-type endopeptidase activity(GO:0004252) |
0.0 | 0.6 | GO:0017166 | vinculin binding(GO:0017166) |
0.0 | 0.5 | GO:0008519 | ammonium transmembrane transporter activity(GO:0008519) |
0.0 | 0.6 | GO:0043014 | alpha-tubulin binding(GO:0043014) |
0.0 | 0.9 | GO:0050840 | extracellular matrix binding(GO:0050840) |
0.0 | 0.8 | GO:0050681 | androgen receptor binding(GO:0050681) |
0.0 | 0.2 | GO:0003997 | acyl-CoA oxidase activity(GO:0003997) |
0.0 | 0.1 | GO:0061676 | importin-alpha family protein binding(GO:0061676) |
0.0 | 0.1 | GO:0050145 | nucleoside phosphate kinase activity(GO:0050145) |
0.0 | 1.7 | GO:0004222 | metalloendopeptidase activity(GO:0004222) |
0.0 | 0.4 | GO:0005234 | extracellular-glutamate-gated ion channel activity(GO:0005234) |
0.0 | 0.6 | GO:1990841 | promoter-specific chromatin binding(GO:1990841) |
0.0 | 1.2 | GO:0005550 | pheromone binding(GO:0005550) |
0.0 | 0.8 | GO:0035255 | ionotropic glutamate receptor binding(GO:0035255) |
0.0 | 0.3 | GO:0071855 | neuropeptide receptor binding(GO:0071855) |
0.0 | 0.1 | GO:0005004 | GPI-linked ephrin receptor activity(GO:0005004) |
0.0 | 0.6 | GO:0051959 | dynein light intermediate chain binding(GO:0051959) |
0.0 | 0.1 | GO:0005105 | type 1 fibroblast growth factor receptor binding(GO:0005105) |
0.0 | 0.5 | GO:0004683 | calmodulin-dependent protein kinase activity(GO:0004683) |
0.0 | 0.3 | GO:0016780 | phosphotransferase activity, for other substituted phosphate groups(GO:0016780) |
0.0 | 0.5 | GO:0071889 | 14-3-3 protein binding(GO:0071889) |
0.0 | 0.2 | GO:0001161 | intronic transcription regulatory region sequence-specific DNA binding(GO:0001161) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.1 | 1.6 | SA REG CASCADE OF CYCLIN EXPR | Expression of cyclins regulates progression through the cell cycle by activating cyclin-dependent kinases. |
0.1 | 2.0 | PID INTEGRIN5 PATHWAY | Beta5 beta6 beta7 and beta8 integrin cell surface interactions |
0.0 | 1.9 | PID ALK1 PATHWAY | ALK1 signaling events |
0.0 | 1.3 | ST MYOCYTE AD PATHWAY | Myocyte Adrenergic Pathway is a specific case of the generalized Adrenergic Pathway. |
0.0 | 0.7 | PID HEDGEHOG 2PATHWAY | Signaling events mediated by the Hedgehog family |
0.0 | 2.3 | PID CASPASE PATHWAY | Caspase cascade in apoptosis |
0.0 | 0.5 | PID ANTHRAX PATHWAY | Cellular roles of Anthrax toxin |
0.0 | 2.3 | PID FGF PATHWAY | FGF signaling pathway |
0.0 | 0.5 | PID ERBB NETWORK PATHWAY | ErbB receptor signaling network |
0.0 | 0.9 | ST PHOSPHOINOSITIDE 3 KINASE PATHWAY | PI3K Pathway |
0.0 | 1.5 | PID AR TF PATHWAY | Regulation of Androgen receptor activity |
0.0 | 0.2 | ST INTERFERON GAMMA PATHWAY | Interferon gamma pathway. |
0.0 | 0.7 | PID LIS1 PATHWAY | Lissencephaly gene (LIS1) in neuronal migration and development |
0.0 | 1.2 | PID LYSOPHOSPHOLIPID PATHWAY | LPA receptor mediated events |
0.0 | 3.6 | NABA ECM REGULATORS | Genes encoding enzymes and their regulators involved in the remodeling of the extracellular matrix |
0.0 | 0.2 | PID GLYPICAN 1PATHWAY | Glypican 1 network |
0.0 | 0.2 | PID FAK PATHWAY | Signaling events mediated by focal adhesion kinase |
0.0 | 0.5 | PID RAS PATHWAY | Regulation of Ras family activation |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.7 | 9.5 | REACTOME REGULATION OF COMPLEMENT CASCADE | Genes involved in Regulation of Complement cascade |
0.2 | 2.8 | REACTOME PASSIVE TRANSPORT BY AQUAPORINS | Genes involved in Passive Transport by Aquaporins |
0.2 | 2.8 | REACTOME TRYPTOPHAN CATABOLISM | Genes involved in Tryptophan catabolism |
0.2 | 0.5 | REACTOME CROSS PRESENTATION OF SOLUBLE EXOGENOUS ANTIGENS ENDOSOMES | Genes involved in Cross-presentation of soluble exogenous antigens (endosomes) |
0.2 | 0.6 | REACTOME DIGESTION OF DIETARY CARBOHYDRATE | Genes involved in Digestion of dietary carbohydrate |
0.1 | 2.6 | REACTOME FGFR4 LIGAND BINDING AND ACTIVATION | Genes involved in FGFR4 ligand binding and activation |
0.1 | 1.2 | REACTOME GLUCURONIDATION | Genes involved in Glucuronidation |
0.1 | 0.8 | REACTOME ACTIVATION OF CHAPERONE GENES BY ATF6 ALPHA | Genes involved in Activation of Chaperone Genes by ATF6-alpha |
0.1 | 1.6 | REACTOME CYCLIN A B1 ASSOCIATED EVENTS DURING G2 M TRANSITION | Genes involved in Cyclin A/B1 associated events during G2/M transition |
0.1 | 2.0 | REACTOME PECAM1 INTERACTIONS | Genes involved in PECAM1 interactions |
0.1 | 1.3 | REACTOME COMPLEMENT CASCADE | Genes involved in Complement cascade |
0.1 | 2.3 | REACTOME CASPASE MEDIATED CLEAVAGE OF CYTOSKELETAL PROTEINS | Genes involved in Caspase-mediated cleavage of cytoskeletal proteins |
0.0 | 1.8 | REACTOME AMINE LIGAND BINDING RECEPTORS | Genes involved in Amine ligand-binding receptors |
0.0 | 1.5 | REACTOME SIGNALING BY FGFR1 FUSION MUTANTS | Genes involved in Signaling by FGFR1 fusion mutants |
0.0 | 0.8 | REACTOME FORMATION OF ATP BY CHEMIOSMOTIC COUPLING | Genes involved in Formation of ATP by chemiosmotic coupling |
0.0 | 1.4 | REACTOME DOWNSTREAM TCR SIGNALING | Genes involved in Downstream TCR signaling |
0.0 | 1.2 | REACTOME SULFUR AMINO ACID METABOLISM | Genes involved in Sulfur amino acid metabolism |
0.0 | 1.0 | REACTOME OTHER SEMAPHORIN INTERACTIONS | Genes involved in Other semaphorin interactions |
0.0 | 1.1 | REACTOME ADHERENS JUNCTIONS INTERACTIONS | Genes involved in Adherens junctions interactions |
0.0 | 0.6 | REACTOME IONOTROPIC ACTIVITY OF KAINATE RECEPTORS | Genes involved in Ionotropic activity of Kainate Receptors |
0.0 | 0.5 | REACTOME JNK C JUN KINASES PHOSPHORYLATION AND ACTIVATION MEDIATED BY ACTIVATED HUMAN TAK1 | Genes involved in JNK (c-Jun kinases) phosphorylation and activation mediated by activated human TAK1 |
0.0 | 0.8 | REACTOME CYTOCHROME P450 ARRANGED BY SUBSTRATE TYPE | Genes involved in Cytochrome P450 - arranged by substrate type |
0.0 | 0.4 | REACTOME MITOCHONDRIAL TRNA AMINOACYLATION | Genes involved in Mitochondrial tRNA aminoacylation |
0.0 | 0.5 | REACTOME GRB2 EVENTS IN ERBB2 SIGNALING | Genes involved in GRB2 events in ERBB2 signaling |
0.0 | 1.2 | REACTOME AMINO ACID AND OLIGOPEPTIDE SLC TRANSPORTERS | Genes involved in Amino acid and oligopeptide SLC transporters |
0.0 | 0.2 | REACTOME COMMON PATHWAY | Genes involved in Common Pathway |
0.0 | 0.6 | REACTOME INTERACTION BETWEEN L1 AND ANKYRINS | Genes involved in Interaction between L1 and Ankyrins |
0.0 | 0.5 | REACTOME TIGHT JUNCTION INTERACTIONS | Genes involved in Tight junction interactions |
0.0 | 0.2 | REACTOME SIGNALING BY HIPPO | Genes involved in Signaling by Hippo |
0.0 | 0.4 | REACTOME BIOSYNTHESIS OF THE N GLYCAN PRECURSOR DOLICHOL LIPID LINKED OLIGOSACCHARIDE LLO AND TRANSFER TO A NASCENT PROTEIN | Genes involved in Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein |